Delivery Order SPE2DB20D2014-SPE2DB24FB59J

Award Date 4/11/24
Potential Completion Date 4/12/24
Potential Value $12K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $32,203.18 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract is for the provision of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract valued at $7,259.23 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a specialty pharmaceutical product, with a period of performance through March 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,837.61 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription pharmaceutical product, with a period of performance through March 18, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,576.66 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract, which has an ultimate completion date of March 21, 2024, is for the supply of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. This order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $4,933.64 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,747.18 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through March 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NURTEC ODT 75 MG TABLET 8S medication. The contract has a completion date of February 2, 2024 and a potential value of $7,552.66. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $18,445.91 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company AmerisourceBergen Corporation, for the supply of NURTEC ODT 75 mg tablets. The $10,508.51 contract has a completion date of February 7, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp serves as the prime contractor on this...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a potential value of $78,029.88. The contract has a completion date of March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB59J
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S for a total ceiling value of $12,472.34. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific award was not set-aside and represents one of the many firm fixed price task orders issued under the IDC to provide a range of medications and healthcare materials to military treatment programs and medical facilities worldwide.

Generated 7/11/24, 9:53 AM